Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
14.18
-0.10 (-0.70%)
Dec 5, 2025, 4:00 PM EST - Market closed
Takeda Pharmaceutical Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Takeda Pharmaceutical.
Price Target: $0.00 (0.00%)
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Takeda Pharmaceutical.
Recommendation Trends
| Rating | Dec '22 | Jan '23 | Feb '23 | Mar '23 | Apr '23 | May '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $30 → $20 | Buy | Maintains | $30 → $20 | +41.04% | May 16, 2023 |
| TD Cowen | TD Cowen | Buy Maintains $24 → $30 | Buy | Maintains | $24 → $30 | +111.57% | Apr 4, 2023 |
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $20 | Hold → Strong Buy | Upgrades | $20 | +41.04% | Mar 16, 2023 |
| Cowen & Co. | Cowen & Co. | Hold → Buy Upgrades $21 → $24 | Hold → Buy | Upgrades | $21 → $24 | +69.25% | Jul 19, 2022 |
| Cowen & Co. | Cowen & Co. | Hold Initiates $20 | Hold | Initiates | $20 | +37.52% | Nov 1, 2019 |
Financial Forecast
Revenue This Year
4,567.95B
from 4,581.55B
Decreased by -0.30%
Revenue Next Year
4,594.91B
from 4,567.95B
Increased by 0.59%
EPS This Year
134.50
from 67.23
Increased by 100.07%
EPS Next Year
198.80
from 134.50
Increased by 47.80%
Financial currency is JPY. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.9T | 5.0T | |
| Avg | 4.6T | 4.6T | |
| Low | 4.4T | 4.3T |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.2% | 8.8% | |
| Avg | -0.3% | 0.6% | |
| Low | -4.8% | -6.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 205.28 | 268.50 | |
| Avg | 134.50 | 198.80 | |
| Low | 95.06 | 132.30 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 205.3% | 99.6% | |
| Avg | 100.1% | 47.8% | |
| Low | 41.4% | -1.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.